Healthcare professionals are valuable allies for pharmaceutical companies, striving to monitor the safety profile of their drugs and to promote their products’ safe and effective use. Good pharmacovigilance practice of pharmaceutical companies have the power to build trust and confidence among patients when using their medicinal products.
Moreover, consistent and robust safety data collected in the post marketing phase can dispel myths and rumors about adverse drug reactions (ADRs) to medicines.
For this reason, it is fundamental for pharma companies to share the culture of reporting among healthcare professionals who are the major providers of spontaneous reports of ADRs